Samir D. Sharma1, Diego Hernando1, Takeshi Yokoo2, Mustafa R. Bashir3,4, Jean Shaffer3,4, Qing Yuan2, Stefan Ruschke5, Dimitrios C. Karampinos5, Jean H. Brittain1, and Scott B. Reeder1,6
1Radiology, University of Wisconsin - Madison, Madison, WI, United States, 2Radiology, UT Southwestern Medical Center, Dallas, TX, United States, 3Radiology, Duke University, Durham, NC, United States, 4Center for Advanced Magnetic Resonance Development, Duke University, Durham, NC, United States, 5Diagnostic and Interventional Radiology, Technische Universität München, Munich, Germany, 6Medical Physics, University of Wisconsin-Madison, Madison, WI, United States
Synopsis
The
need for rapid and non-invasive assessment of fat and iron deposition has
become increasingly important given the high prevalence of obesity and
obesity-related comorbidities as well as the need for monitoring
chelation treatment in patients with iron overload. Recent
advances in gradient-echo imaging have enabled the simultaneous quantification
of fat and iron concentrations throughout the body. To ensure fidelity
of these quantitative techniques, validation studies must be performed, ideally
with initial testing in phantoms.
In
this work, we report on the development of a water-fat-iron MRI phantom that
exhibits single-R2* decay, with controllable proton-density fat fraction (PDFF)
and iron concentration. The purpose of this work is: 1) to describe
the development of the water-fat-iron phantom, and 2) to assess the multi-center,
multi-vendor reproducibility of joint fat and iron quantification using this phantom.Purpose
The
need for rapid and non-invasive assessment of fat and iron deposition has
become increasingly important given the high prevalence of obesity and
obesity-related comorbidities
1 as well as the need for monitoring
chelation treatment in patients with iron overload. Recent advances in
gradient-echo imaging have enabled the simultaneous quantification of fat and
iron concentrations throughout the body
2. To ensure fidelity of
these quantitative techniques, validation studies must be performed, ideally
with initial testing in phantoms containing known values of fat and iron, and
later in patients. However, previously developed water-fat-iron phantoms
3
do not accurately reflect the MR signal that has been observed in-vivo,
particularly in the liver. Specifically, experiments have demonstrated that previous
phantoms exhibit different transverse relaxation rates for the water and fat
components (dual-R2*), whereas in-vivo liver experiments have demonstrated very
similar R2* values for water and fat (single-R2*) in the presence of iron. In
this work, we report on the development of a water-fat-iron MRI phantom that
exhibits single-R2* decay, with controllable proton-density fat fraction (PDFF)
and iron concentration.
The purpose of this work is: 1) to describe
the development of the water-fat-iron phantom, and 2) to assess the multi-center,
multi-vendor reproducibility of joint fat and iron quantification using this phantom.
Methods
Water-Fat-Iron
Phantom: The water-fat-iron phantom contains
multiple vials, each consisting of deionized water, a 20% fat emulsion
(Intralipid, Fresenius Kabi, Sweden), and superparamagnetic iron-oxide (SPIO)
particles (COMPEL, Bangs Labs, Fishers, IN). Other ingredients include: agar (forms
gel), sodium chloride (coil loading), sodium benzoate (preservative), and
copper sulfate (shortens T1). The ratio of deionized water and Intralipid
controls the PDFF, while the amount of SPIOs controls the iron concentration. The
main innovation of this development is the use of small fat particles (0.5um) relative
to the size of the iron-oxide particles (6um). The magnetic field disturbances
induced by the SPIOs affect the water and fat components similarly, resulting
in single-R2* decay behavior.
Phantom Construction:
A water-fat-iron phantom was constructed at the host site using 40 mL
cylindrical vials. 30 vials were constructed, each consisting of a unique
combination of proton density fat fraction (PDFF) and iron concentration
(measured by R2*). The prescribed PDFF ranged between 0-20% and the iron
concentrations ranged between 0-0.1mg Fe/L solution (R2* ~30-630 s-1)
(Figure 1).
Imaging Sites:
The phantom was scanned at three different sites, each with a unique scanner
vendor (GE, Philips, and Siemens). At each site, the phantom was scanned at
both 1.5T and 3T using a 3D multi-echo, spoiled-gradient-echo sequence, with acquisition
parameters: TE1=0.9ms, ΔTE=0.9ms,
number of echoes=12, slice thickness=4mm, flip angle=5°(1.5T) and 3°(3T), and
48 slices. The complex-valued source images were sent to the host site for
processing. Upon completion of scanning, the phantom was shipped to the next
site. After scanning at all three sites, the phantom was returned to the host
site for final analysis.
Image Reconstruction
and Analysis: Proton-density-weighted water and fat
images and an R2* map were reconstructed from the source images using a nonlinear
least-squares chemical shift encoded reconstruction4. This
reconstruction accounted for the multi-peak fat spectrum5, eddy
currents6, and temperature-related chemical shifts7. The
PDFF was calculated from the water and fat images with correction for noise
bias. For each vial, an ROI (~2cm diameter) was drawn in the three central
slices of the PDFF and R2* maps. The recorded measurement for that vial was
calculated as the average of the PDFF (or R2*) over the three slices. Bland-Altman
analyses were performed to examine the agreement in PDFF and R2* between the
different sites.
Results
During
shipment between sites, some of the vials were physically damaged (broken
and/or leaking). Those vials were excluded from analysis due to concerns about changes in the MR properties of the contents. Fortunately, the
undamaged vials contained nonzero fat concentration and a full range of iron
concentration. For these remaining vials, scanning was successfully completed
at all sites and subsequently repeated at the host site. Bland-Altman analyses
for both the PDFF and the R2* measurements at 1.5T and 3T are shown in Figure 2.
The 95% limits of agreement between sites are summarized in Figure 3. Strong
agreement was observed between sites for PDFF and R2* measurements at both 1.5T
and 3T.
Discussion & Conclusion
We
have reported on the development of a novel water-fat-iron phantom for
quantitative MR. The phantom enables controlled validation of techniques for
joint fat and iron quantification. Further, this phantom has enabled preliminary
validation of the reproducibility of joint fat and iron quantification techniques
across multiple centers and multiple vendors at both 1.5T and 3T.
Acknowledgements
The authors acknowledge the support of the NIH (R01DK083380,
R01DK088925, and R01DK100651), Radiology R&D, and the Discovery to Product
(D2P) Igniter program. We also wish to thank GE Healthcare, Philips Healthcare,
and Siemens Healthcare for their support.References
1Byrne. Diabetic Medicine 2012;29:1098-1107.
2Yu
et al. MRM 2008;60:1122-1134.
3Hines et al. JMRI 2009;30:1215-1222.
4Hernando
et al. MRM 2013;70:1319-1331.
5Hamilton et al. NMR Biomed
2011;24:784-790.
6Bydder et al. MRI 2008;26:347-359.
7Hernando
et al. MRM 2013;72:464-470.